Reindl-Schwaighofer Roman, Kainz Alexander, Kammer Michael, Dumfarth Alexandra, Oberbauer Rainer
Department of Nephrology, Krankenhaus der Elisabethinen, Linz, Austria.
Department of Nephrology, Medical University of Vienna, Vienna, Austria.
PLoS One. 2017 Jul 24;12(7):e0181345. doi: 10.1371/journal.pone.0181345. eCollection 2017.
Elderly patients represent a growing population among people suffering from ESRD. So far only limited data on actual survival benefits of elderly adults initiating dialysis have been published. Besides the high burden of preexisting comorbidities, dialysis treatment itself may be associated with a further deterioration in functional status in this population. We retrospectively analyzed the Austrian Dialysis and Transplant Registry and identified 8,622 patients who started maintenance hemodialysis after the age of 65 years between 2002 and 2009. We compared this data set to a cohort of 174 patients aged over 65 years with CKD stage 5 who progressed to an eGFR < 10ml/min/ and were managed conservatively in the same era. All patients who died of malignant disease were excluded from this analysis. The risk of mortality was analyzed using multivariable Cox proportional hazards models. Furthermore, a parametric model of time to event analysis was used for visualization of changing risk over time and precise calculation of time to equal risk assuming a Weibull distribution. Hemodialysis treatment was associated with a decreased risk for death with a HR of 0.23 (95% CI 0.18 to 0.29; p<0.001) compared to conservative treatment. The time to event analysis however showed, that although survival was initially superior in the hemodialysis group, hazards crossed thereafter. Time to equal risk was 2.9 months and 1.9 months for female and male patient aged 65, respectively, and decreased to one month in the very elderly aged 95. Elderly patients with ERSD did benefit from initiation of hemodialysis, as the conservative group showed a very high initial mortality rate. This survival benefit of dialysis treatment however did not persist beyond the first two months compared to survivors of the conservative group.
老年患者在终末期肾病(ESRD)患者中所占比例日益增加。迄今为止,关于老年成年人开始透析的实际生存益处的公开数据有限。除了存在的合并症负担较重外,透析治疗本身可能与该人群功能状态的进一步恶化有关。我们回顾性分析了奥地利透析与移植登记处的数据,确定了2002年至2009年间65岁以后开始维持性血液透析的8622例患者。我们将该数据集与同一时期174例年龄超过65岁、慢性肾脏病(CKD)5期且估算肾小球滤过率(eGFR)进展至<10ml/min/并接受保守治疗的患者队列进行了比较。所有死于恶性疾病的患者均被排除在该分析之外。使用多变量Cox比例风险模型分析死亡风险。此外,采用事件发生时间分析的参数模型来直观呈现随时间变化的风险,并在假设为威布尔分布的情况下精确计算等风险时间。与保守治疗相比,血液透析治疗使死亡风险降低,风险比(HR)为0.23(95%置信区间为0.18至0.29;p<0.001)。然而,事件发生时间分析表明,尽管血液透析组的生存情况最初更优,但此后风险交叉。65岁女性和男性患者的等风险时间分别为2.9个月和1.9个月,在95岁的高龄患者中降至1个月。患有ESRD的老年患者确实从开始血液透析中获益,因为保守治疗组的初始死亡率非常高。然而,与保守治疗组的幸存者相比,透析治疗的这种生存益处在前两个月之后并未持续。